European Growth Companies With Insider Confidence November 2025
Reviewed by Simply Wall St
In recent weeks, European markets have experienced declines, with the pan-European STOXX Europe 600 Index falling by 2.21% amid concerns over inflated AI stock valuations and receding expectations for a U.S. interest rate cut. Despite these challenges, eurozone business activity has shown steady expansion, suggesting resilience in certain sectors. In this environment of market uncertainty, growth companies with high insider ownership can be particularly appealing to investors due to the potential alignment of interests between insiders and shareholders, indicating confidence in the company's future prospects amidst broader economic fluctuations.
Top 10 Growth Companies With High Insider Ownership In Europe
| Name | Insider Ownership | Earnings Growth |
| Pharma Mar (BME:PHM) | 12% | 41.5% |
| MilDef Group (OM:MILDEF) | 13.7% | 83% |
| MedinCell (ENXTPA:MEDCL) | 12.5% | 96.3% |
| KebNi (OM:KEBNI B) | 36.3% | 61.2% |
| Elliptic Laboratories (OB:ELABS) | 22.5% | 109.1% |
| DNO (OB:DNO) | 13.5% | 97.5% |
| CTT Systems (OM:CTT) | 17.5% | 52% |
| Circus (XTRA:CA1) | 24.1% | 65.8% |
| CD Projekt (WSE:CDR) | 29.7% | 50.6% |
| Bonesupport Holding (OM:BONEX) | 10.4% | 49.7% |
Here we highlight a subset of our preferred stocks from the screener.
Ercros (BME:ECR)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Ercros, S.A. is a Spanish company engaged in the manufacturing and sale of basic chemicals, intermediate chemicals, and pharmaceuticals with a market cap of €302.65 million.
Operations: The company's revenue segments include €62.24 million from pharmaceuticals, €376.44 million from chlorine derivatives, and €182.19 million from intermediate chemicals.
Insider Ownership: 15.9%
Ercros, S.A. shows potential as a growth company with high insider ownership in Europe. Despite a recent net loss of €41.22 million for the first nine months of 2025, Ercros is forecast to achieve profitability within three years, outpacing average market growth. Revenue is expected to grow at 9.6% annually, surpassing the Spanish market rate. However, its dividend yield of 2.9% lacks coverage by free cash flows and share price has been volatile recently.
- Click to explore a detailed breakdown of our findings in Ercros' earnings growth report.
- Upon reviewing our latest valuation report, Ercros' share price might be too pessimistic.
Bonesupport Holding (OM:BONEX)
Simply Wall St Growth Rating: ★★★★★★
Overview: Bonesupport Holding AB is an orthobiologics company that develops and sells injectable bio-ceramic bone graft substitutes across Europe, North America, and internationally, with a market cap of SEK13.29 billion.
Operations: The company generates revenue primarily from its Pharmaceuticals segment, which reported SEK1.12 billion.
Insider Ownership: 10.4%
Bonesupport Holding demonstrates strong growth potential, with earnings forecasted to grow 49.7% annually, significantly outpacing the Swedish market. Recent earnings reports show a robust increase in revenue and net income for the third quarter of 2025. The company trades at a substantial discount to its estimated fair value and has reported positive clinical results for CERAMENT® G, enhancing its market position in orthopedic treatments. Despite high insider ownership, no recent insider trading activity is noted.
- Take a closer look at Bonesupport Holding's potential here in our earnings growth report.
- Our valuation report here indicates Bonesupport Holding may be undervalued.
Shoper (WSE:SHO)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Shoper S.A. offers software as a service solutions for e-commerce in Poland and has a market capitalization of PLN1.42 billion.
Operations: The company's revenue is derived from two main segments: Solutions, contributing PLN168.70 million, and Subscriptions, accounting for PLN44.74 million.
Insider Ownership: 22.5%
Shoper S.A. exhibits promising growth prospects, with earnings expected to grow significantly at 22.2% annually, surpassing the Polish market's average. Recent earnings reports reveal an increase in revenue and net income for the nine months ending September 2025, reflecting strong operational performance. The stock is trading below its estimated fair value and has been added to the S&P Global BMI Index, indicating positive investor sentiment despite no recent insider trading activity being reported.
- Click here and access our complete growth analysis report to understand the dynamics of Shoper.
- Upon reviewing our latest valuation report, Shoper's share price might be too optimistic.
Turning Ideas Into Actions
- Embark on your investment journey to our 202 Fast Growing European Companies With High Insider Ownership selection here.
- Ready To Venture Into Other Investment Styles? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 35 best rare earth metal stocks of the very few that mine this essential strategic resource.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About WSE:SHO
High growth potential with solid track record.
Market Insights
Community Narratives


Recently Updated Narratives
TAV Havalimanlari Holding will fly high with 25.68% revenue growth

Fiducian: Compliance Clouds or Value Opportunity?

Q3 Outlook modestly optimistic
Popular Narratives

MicroVision will explode future revenue by 380.37% with a vision towards success

The company that turned a verb into a global necessity and basically runs the modern internet, digital ads, smartphones, maps, and AI.
